BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, April 23, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Aug. 1, 2011
View Archived Issues
New TNF receptor superfamily member 16 antagonists claimed
Read More
Novel ionotropic glutamate receptor modulators prepared by Servier
Read More
Laboratoires Fournier claims new agents for neurodegenerative diseases
Read More
ArQule presents novel inhibitors of cyclin-dependent kinase 7 and CaMK-II
Read More
Gene therapy reverses and prevents heart failure after ischemia in preclinical study
Read More
Novel metabotropic glutamate mGlu5 receptor agonists reported
Read More
Sorrento Therapeutics receives NIH grant for CDI program
Read More
Antisense morpholino oligomer holds promise in treatment of Duchenne's muscular dystrophy
Read More
Cogane obtains orphan drug status in U.S.
Read More
Scynexis synthesizes new agents for hepatitis C
Read More
ISTA Pharmaceuticals reports data from phase III Remura trials
Read More
Invaron Pharmaceuticals obtains license for Striant
Read More
Statin therapy may reduce cardiovascular risk in patients with SLE
Read More
RaQualia grants rights for serotonin 5-HT4 partial agonist to CJ CheilJedang
Read More
Polaris doses first patient in pivotal phase III ADI-PEG 20 trial
Read More
Shionogi & Co. enters agreement to acquire C&O Pharmaceutical Technology
Read More
Nippon Chemiphar discontinues development of cathepsin K inhibitor licensed to Velcura
Read More
Baxter launches inhaled general anesthetic in Japan
Read More
Soligenix expands orBec partnership with Sigma-Tau
Read More
Preclinical and clinical data presented on new serotonin 5-HT4 receptor partial agonist PF-04995274
Read More
Lilly and Lupin enter collaboration for diabetes therapies
Read More
Highlights of Chugai's second quarter of 2011
Read More
FDA extends review of Pfizer's sBLA for Prevnar 13
Read More
Labopharm and Angelini Group restructure joint venture for Oleptro
Read More
FDA approves subcutaneous formulation of Orencia
Read More